145 related articles for article (PubMed ID: 37788373)
1. Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody-Drug Conjugates.
Marvin CC; Hobson AD; McPherson M; Dunstan TA; Vargo TR; Hayes ME; Fettis MM; Bischoff A; Wang L; Wang L; Hernandez A; Jia Y; Oh JZ; Tian Y
Bioconjug Chem; 2023 Oct; 34(10):1835-1850. PubMed ID: 37788373
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates.
Jeffrey SC; Torgov MY; Andreyka JB; Boddington L; Cerveny CG; Denny WA; Gordon KA; Gustin D; Haugen J; Kline T; Nguyen MT; Senter PD
J Med Chem; 2005 Mar; 48(5):1344-58. PubMed ID: 15743178
[TBL] [Abstract][Full Text] [Related]
3. The Methylene Alkoxy Carbamate Self-Immolative Unit: Utilization for the Targeted Delivery of Alcohol-Containing Payloads with Antibody-Drug Conjugates.
Kolakowski RV; Haelsig KT; Emmerton KK; Leiske CI; Miyamoto JB; Cochran JH; Lyon RP; Senter PD; Jeffrey SC
Angew Chem Int Ed Engl; 2016 Jul; 55(28):7948-51. PubMed ID: 27198854
[TBL] [Abstract][Full Text] [Related]
4. Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design.
Dorywalska M; Dushin R; Moine L; Farias SE; Zhou D; Navaratnam T; Lui V; Hasa-Moreno A; Casas MG; Tran TT; Delaria K; Liu SH; Foletti D; O'Donnell CJ; Pons J; Shelton DL; Rajpal A; Strop P
Mol Cancer Ther; 2016 May; 15(5):958-70. PubMed ID: 26944918
[TBL] [Abstract][Full Text] [Related]
5. Late-Stage Desulfurization Enables Rapid and Efficient Solid-Phase Synthesis of Cathepsin-Cleavable Linkers for Antibody-Drug Conjugates.
Ahangarpour M; Brimble MA; Kavianinia I
Bioconjug Chem; 2024 Jun; ():. PubMed ID: 38874557
[TBL] [Abstract][Full Text] [Related]
6. Effect of attachment site on stability of cleavable antibody drug conjugates.
Dorywalska M; Strop P; Melton-Witt JA; Hasa-Moreno A; Farias SE; Galindo Casas M; Delaria K; Lui V; Poulsen K; Loo C; Krimm S; Bolton G; Moine L; Dushin R; Tran TT; Liu SH; Rickert M; Foletti D; Shelton DL; Pons J; Rajpal A
Bioconjug Chem; 2015 Apr; 26(4):650-9. PubMed ID: 25643134
[TBL] [Abstract][Full Text] [Related]
7. Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment.
Edupuganti VVSR; Tyndall JDATDA; Gamble AB
Recent Pat Anticancer Drug Discov; 2021; 16(4):479-497. PubMed ID: 33966624
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Evaluation of a Carbamate-Containing Tubulysin Antibody-Drug Conjugate.
Cheng H; Cong Q; Dervin D; Stevens A; Vemuri K; Huber M; Juliano J; Cuison S; Sung J; Passmore D; Chong C; Greenbaum M; Kwok E; Jiang J; Pan C; Rao-Naik C; Rangan V; Kempe T; Tatum A; Deshpande S; Cardarelli P; Vite G; Gangwar S
Bioconjug Chem; 2020 Oct; 31(10):2350-2361. PubMed ID: 32881482
[TBL] [Abstract][Full Text] [Related]
9. Chemical Modification of Linkers Provides Stable Linker-Payloads for the Generation of Antibody-Drug Conjugates.
Poudel YB; Chowdari NS; Cheng H; Iwuagwu CI; King HD; Kotapati S; Passmore D; Rampulla R; Mathur A; Vite G; Gangwar S
ACS Med Chem Lett; 2020 Nov; 11(11):2190-2194. PubMed ID: 33214828
[TBL] [Abstract][Full Text] [Related]
10. Novel Phosphate Modified Cathepsin B Linkers: Improving Aqueous Solubility and Enhancing Payload Scope of ADCs.
Kern JC; Dooney D; Zhang R; Liang L; Brandish PE; Cheng M; Feng G; Beck A; Bresson D; Firdos J; Gately D; Knudsen N; Manibusan A; Sun Y; Garbaccio RM
Bioconjug Chem; 2016 Sep; 27(9):2081-8. PubMed ID: 27469406
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates.
Tedeschini T; Campara B; Grigoletto A; Bellini M; Salvalaio M; Matsuno Y; Suzuki A; Yoshioka H; Pasut G
J Control Release; 2021 Sep; 337():431-447. PubMed ID: 34329685
[TBL] [Abstract][Full Text] [Related]
12. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates.
Frigerio M; Kyle AF
Curr Top Med Chem; 2017; 17(32):3393-3424. PubMed ID: 29357801
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and targeted chemotherapy of SCT200-linker-monomethyl auristatin E conjugates.
Hu X; Jiang H; Bai W; Liu X; Miao Q; Wang L; Jin J; Cui A; Liu R; Li Z
Eur J Med Chem; 2021 Apr; 216():113297. PubMed ID: 33677351
[TBL] [Abstract][Full Text] [Related]
14. Targeted Fluorogenic Cyanine Carbamates Enable
Usama SM; Marker SC; Caldwell DR; Patel NL; Feng Y; Kalen JD; St Croix B; Schnermann MJ
J Am Chem Soc; 2021 Dec; 143(51):21667-21675. PubMed ID: 34928588
[TBL] [Abstract][Full Text] [Related]
15. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)].
Tsuchikama K
Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230
[TBL] [Abstract][Full Text] [Related]
16. Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates.
Burke PJ; Hamilton JZ; Pires TA; Setter JR; Hunter JH; Cochran JH; Waight AB; Gordon KA; Toki BE; Emmerton KK; Zeng W; Stone IJ; Senter PD; Lyon RP; Jeffrey SC
Mol Cancer Ther; 2016 May; 15(5):938-45. PubMed ID: 26944920
[TBL] [Abstract][Full Text] [Related]
17. Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers.
Salomon PL; Reid EE; Archer KE; Harris L; Maloney EK; Wilhelm AJ; Miller ML; Chari RVJ; Keating TA; Singh R
Mol Pharm; 2019 Dec; 16(12):4817-4825. PubMed ID: 31609629
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody-Drug Conjugates.
Kern JC; Cancilla M; Dooney D; Kwasnjuk K; Zhang R; Beaumont M; Figueroa I; Hsieh S; Liang L; Tomazela D; Zhang J; Brandish PE; Palmieri A; Stivers P; Cheng M; Feng G; Geda P; Shah S; Beck A; Bresson D; Firdos J; Gately D; Knudsen N; Manibusan A; Schultz PG; Sun Y; Garbaccio RM
J Am Chem Soc; 2016 Feb; 138(4):1430-45. PubMed ID: 26745435
[TBL] [Abstract][Full Text] [Related]
19. Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers.
Pillow TH; Schutten M; Yu SF; Ohri R; Sadowsky J; Poon KA; Solis W; Zhong F; Del Rosario G; Go MAT; Lau J; Yee S; He J; Liu L; Ng C; Xu K; Leipold DD; Kamath AV; Zhang D; Masterson L; Gregson SJ; Howard PW; Fang F; Chen J; Gunzner-Toste J; Kozak KK; Spencer S; Polakis P; Polson AG; Flygare JA; Junutula JR
Mol Cancer Ther; 2017 May; 16(5):871-878. PubMed ID: 28223423
[TBL] [Abstract][Full Text] [Related]
20. Tandem-Cleavage Linkers Improve the In Vivo Stability and Tolerability of Antibody-Drug Conjugates.
Chuprakov S; Ogunkoya AO; Barfield RM; Bauzon M; Hickle C; Kim YC; Yeo D; Zhang F; Rabuka D; Drake PM
Bioconjug Chem; 2021 Apr; 32(4):746-754. PubMed ID: 33689309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
